Medifast (MED) Tops Q3 EPS by 105c

Medifast (NYSE: MED) reported Q3 EPS of $2.12, $1.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $235.9 million versus the consensus estimate of $232.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c